Goldman Sachs
SOPH icon

Goldman Sachs’s SOPHiA GENETICS SOPH Stock Holding History

Goldman Sachs’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171K Sell
29,598
-28,030
-49% -$142K ﹤0.01% 6237
2026
Q1 		$285K Buy
57,628
+28,968
+101% +$141K ﹤0.01% 5919
2025
Q4 		$134K Buy
28,660
+1,453
+5% +$6.58K ﹤0.01% 6141
2025
Q3 		$130K Buy
27,207
+8,828
+48% +$30.3K ﹤0.01% 6033
2025
Q2 		$57K Buy
+18,379
New +$54.8K ﹤0.01% 5896

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Goldman Sachs's SOPH Position: Q2 2026 in Review

Goldman Sachs reduced its SOPHiA GENETICS (SOPH) stake by 49% in Q2 2026, selling an estimated $142K and leaving 29,598 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #6237.

Goldman Sachs first reported a position in SOPH in Q2 2025 and has held it in 5 quarters since. The position peaked at $285K in Q1 2026. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Goldman Sachs held 29,598 shares of SOPHiA GENETICS worth $171K as of Q2 2026.
  • Goldman Sachs sold 28,030 SOPHiA GENETICS shares in Q2 2026, an estimated $142K.
  • SOPHiA GENETICS made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6237 holding.
  • Goldman Sachs first reported a position in SOPHiA GENETICS in Q2 2025 and has held it in 5 quarters since.
  • Goldman Sachs's SOPHiA GENETICS position peaked at $285K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.